APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pertuzumab

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pertuzumab Market Analysis and Forecast 2026-2032

26 December 2025192 pages

Choose your research edition.

Industry ResearchPertuzumab Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Pertuzumab Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Pertuzumab Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pertuzumab Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Pertuzumab Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Pertuzumab market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pertuzumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pertuzumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pertuzumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pertuzumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Pertuzumab include Abnova Corporation, Biocon Limited, Bio-Techne, Celltrion, InvivoGen, Pfizer and Novartis AG, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pertuzumab, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pertuzumab, also provides the sales of main regions and countries. Of the upcoming market potential for Pertuzumab, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pertuzumab sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pertuzumab market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pertuzumab sales, projected growth trends, production technology, application and end-user industry.

Pertuzumab Segment by Company

Abnova Corporation

Biocon Limited

Bio-Techne

Celltrion

InvivoGen

Pfizer

Novartis AG

Pertuzumab Segment by Type

Human Source

Animal Source

Pertuzumab Segment by Application

Hospital

Medical Center

Pertuzumab Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pertuzumab market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pertuzumab and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pertuzumab.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Pertuzumab in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Pertuzumab manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pertuzumab sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pertuzumab Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Human Source Major Manufacturers Table 3. Animal Source Major Manufacturers Table 4. Global Pertuzumab Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Medical Center Major Manufacturers Table 7. Pertuzumab Industry Trends Table 8. Pertuzumab Industry Drivers Table 9. Pertuzumab Industry Opportunities and Challenges Table 10. Pertuzumab Industry Restraints Table 11. Global Pertuzumab Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Pertuzumab Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Pertuzumab Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Pertuzumab Revenue Market Share by Region (2021-2026) Table 15. Global Pertuzumab Revenue Market Share by Region (2027-2032) Table 16. Global Pertuzumab Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 17. Global Pertuzumab Sales by Region (2021-2026) & (Tons) Table 18. Global Pertuzumab Sales by Region (2027-2032) & (Tons) Table 19. Global Pertuzumab Sales Market Share by Region (2021-2026) Table 20. Global Pertuzumab Sales Market Share by Region (2027-2032) Table 21. Global Pertuzumab Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Pertuzumab Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Pertuzumab Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Pertuzumab Sales Market Share by Manufacturers (2021-2026) Table 25. Global Pertuzumab Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 26. Global Pertuzumab Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Pertuzumab Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Pertuzumab Manufacturers, Product Type & Application Table 29. Global Pertuzumab Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Pertuzumab by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Pertuzumab Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Pertuzumab Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Pertuzumab Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Pertuzumab Revenue Market Share by Type (2021-2026) Table 36. Global Pertuzumab Revenue Market Share by Type (2027-2032) Table 37. Global Pertuzumab Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 38. Global Pertuzumab Sales by Type (2021-2026) & (Tons) Table 39. Global Pertuzumab Sales by Type (2027-2032) & (Tons) Table 40. Global Pertuzumab Sales Market Share by Type (2021-2026) Table 41. Global Pertuzumab Sales Market Share by Type (2027-2032) Table 42. Global Pertuzumab Price by Type (2021-2026) & (US$/Ton) Table 43. Global Pertuzumab Price by Type (2027-2032) & (US$/Ton) Table 44. Global Pertuzumab Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Pertuzumab Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Pertuzumab Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Pertuzumab Revenue Market Share by Application (2021-2026) Table 48. Global Pertuzumab Revenue Market Share by Application (2027-2032) Table 49. Global Pertuzumab Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 50. Global Pertuzumab Sales by Application (2021-2026) & (Tons) Table 51. Global Pertuzumab Sales by Application (2027-2032) & (Tons) Table 52. Global Pertuzumab Sales Market Share by Application (2021-2026) Table 53. Global Pertuzumab Sales Market Share by Application (2027-2032) Table 54. Global Pertuzumab Price by Application (2021-2026) & (US$/Ton) Table 55. Global Pertuzumab Price by Application (2027-2032) & (US$/Ton) Table 56. Abnova Corporation Company Information Table 57. Abnova Corporation Business Overview Table 58. Abnova Corporation Pertuzumab Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 59. Abnova Corporation Pertuzumab Product Portfolio Table 60. Abnova Corporation Recent Development Table 61. Biocon Limited Company Information Table 62. Biocon Limited Business Overview Table 63. Biocon Limited Pertuzumab Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 64. Biocon Limited Pertuzumab Product Portfolio Table 65. Biocon Limited Recent Development Table 66. Bio-Techne Company Information Table 67. Bio-Techne Business Overview Table 68. Bio-Techne Pertuzumab Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 69. Bio-Techne Pertuzumab Product Portfolio Table 70. Bio-Techne Recent Development Table 71. Celltrion Company Information Table 72. Celltrion Business Overview Table 73. Celltrion Pertuzumab Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 74. Celltrion Pertuzumab Product Portfolio Table 75. Celltrion Recent Development Table 76. InvivoGen Company Information Table 77. InvivoGen Business Overview Table 78. InvivoGen Pertuzumab Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 79. InvivoGen Pertuzumab Product Portfolio Table 80. InvivoGen Recent Development Table 81. Pfizer Company Information Table 82. Pfizer Business Overview Table 83. Pfizer Pertuzumab Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 84. Pfizer Pertuzumab Product Portfolio Table 85. Pfizer Recent Development Table 86. Novartis AG Company Information Table 87. Novartis AG Business Overview Table 88. Novartis AG Pertuzumab Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 89. Novartis AG Pertuzumab Product Portfolio Table 90. Novartis AG Recent Development Table 91. North America Pertuzumab Revenue by Type (2021-2026) & (US$ Million) Table 92. North America Pertuzumab Revenue by Type (2027-2032) & (US$ Million) Table 93. North America Pertuzumab Sales by Type (2021-2026) & (Tons) Table 94. North America Pertuzumab Sales by Type (2027-2032) & (Tons) Table 95. North America Pertuzumab Sales Price by Type (2021-2026) & (US$/Ton) Table 96. North America Pertuzumab Sales Price by Type (2027-2032) & (US$/Ton) Table 97. North America Pertuzumab Revenue by Application (2021-2026) & (US$ Million) Table 98. North America Pertuzumab Revenue by Application (2027-2032) & (US$ Million) Table 99. North America Pertuzumab Sales by Application (2021-2026) & (Tons) Table 100. North America Pertuzumab Sales by Application (2027-2032) & (Tons) Table 101. North America Pertuzumab Sales Price by Application (2021-2026) & (US$/Ton) Table 102. North America Pertuzumab Sales Price by Application (2027-2032) & (US$/Ton) Table 103. North America Pertuzumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. North America Pertuzumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 105. North America Pertuzumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 106. North America Pertuzumab Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 107. North America Pertuzumab Sales by Country (2021-2026) & (Tons) Table 108. North America Pertuzumab Sales by Country (2027-2032) & (Tons) Table 109. North America Pertuzumab Sales Price by Country (2021-2026) & (US$/Ton) Table 110. North America Pertuzumab Sales Price by Country (2027-2032) & (US$/Ton) Table 111. United States Pertuzumab Revenue (2021-2032) & (US$ Million) Table 112. Canada Pertuzumab Revenue (2021-2032) & (US$ Million) Table 113. Mexico Pertuzumab Revenue (2021-2032) & (US$ Million) Table 114. Europe Pertuzumab Revenue by Type (2021-2026) & (US$ Million) Table 115. Europe Pertuzumab Revenue by Type (2027-2032) & (US$ Million) Table 116. Europe Pertuzumab Sales by Type (2021-2026) & (Tons) Table 117. Europe Pertuzumab Sales by Type (2027-2032) & (Tons) Table 118. Europe Pertuzumab Sales Price by Type (2021-2026) & (US$/Ton) Table 119. Europe Pertuzumab Sales Price by Type (2027-2032) & (US$/Ton) Table 120. Europe Pertuzumab Revenue by Application (2021-2026) & (US$ Million) Table 121. Europe Pertuzumab Revenue by Application (2027-2032) & (US$ Million) Table 122. Europe Pertuzumab Sales by Application (2021-2026) & (Tons) Table 123. Europe Pertuzumab Sales by Application (2027-2032) & (Tons) Table 124. Europe Pertuzumab Sales Price by Application (2021-2026) & (US$/Ton) Table 125. Europe Pertuzumab Sales Price by Application (2027-2032) & (US$/Ton) Table 126. Europe Pertuzumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. Europe Pertuzumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 128. Europe Pertuzumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 129. Europe Pertuzumab Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 130. Europe Pertuzumab Sales by Country (2021-2026) & (Tons) Table 131. Europe Pertuzumab Sales by Country (2027-2032) & (Tons) Table 132. Europe Pertuzumab Sales Price by Country (2021-2026) & (US$/Ton) Table 133. Europe Pertuzumab Sales Price by Country (2027-2032) & (US$/Ton) Table 134. Germany Pertuzumab Revenue (2021-2032) & (US$ Million) Table 135. France Pertuzumab Revenue (2021-2032) & (US$ Million) Table 136. U.K. Pertuzumab Revenue (2021-2032) & (US$ Million) Table 137. Italy Pertuzumab Revenue (2021-2032) & (US$ Million) Table 138. Russia Pertuzumab Revenue (2021-2032) & (US$ Million) Table 139. Spain Pertuzumab Revenue (2021-2032) & (US$ Million) Table 140. Netherlands Pertuzumab Revenue (2021-2032) & (US$ Million) Table 141. Switzerland Pertuzumab Revenue (2021-2032) & (US$ Million) Table 142. Sweden Pertuzumab Revenue (2021-2032) & (US$ Million) Table 143. Poland Pertuzumab Revenue (2021-2032) & (US$ Million) Table 144. China Pertuzumab Revenue by Type (2021-2026) & (US$ Million) Table 145. China Pertuzumab Revenue by Type (2027-2032) & (US$ Million) Table 146. China Pertuzumab Sales by Type (2021-2026) & (Tons) Table 147. China Pertuzumab Sales by Type (2027-2032) & (Tons) Table 148. China Pertuzumab Sales Price by Type (2021-2026) & (US$/Ton) Table 149. China Pertuzumab Sales Price by Type (2027-2032) & (US$/Ton) Table 150. China Pertuzumab Revenue by Application (2021-2026) & (US$ Million) Table 151. China Pertuzumab Revenue by Application (2027-2032) & (US$ Million) Table 152. China Pertuzumab Sales by Application (2021-2026) & (Tons) Table 153. China Pertuzumab Sales by Application (2027-2032) & (Tons) Table 154. China Pertuzumab Sales Price by Application (2021-2026) & (US$/Ton) Table 155. China Pertuzumab Sales Price by Application (2027-2032) & (US$/Ton) Table 156. Asia Pertuzumab Revenue by Type (2021-2026) & (US$ Million) Table 157. Asia Pertuzumab Revenue by Type (2027-2032) & (US$ Million) Table 158. Asia Pertuzumab Sales by Type (2021-2026) & (Tons) Table 159. Asia Pertuzumab Sales by Type (2027-2032) & (Tons) Table 160. Asia Pertuzumab Sales Price by Type (2021-2026) & (US$/Ton) Table 161. Asia Pertuzumab Sales Price by Type (2027-2032) & (US$/Ton) Table 162. Asia Pertuzumab Revenue by Application (2021-2026) & (US$ Million) Table 163. Asia Pertuzumab Revenue by Application (2027-2032) & (US$ Million) Table 164. Asia Pertuzumab Sales by Application (2021-2026) & (Tons) Table 165. Asia Pertuzumab Sales by Application (2027-2032) & (Tons) Table 166. Asia Pertuzumab Sales Price by Application (2021-2026) & (US$/Ton) Table 167. Asia Pertuzumab Sales Price by Application (2027-2032) & (US$/Ton) Table 168. Asia Pertuzumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 169. Asia Pertuzumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 170. Asia Pertuzumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 171. Asia Pertuzumab Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 172. Asia Pertuzumab Sales by Country (2021-2026) & (Tons) Table 173. Asia Pertuzumab Sales by Country (2027-2032) & (Tons) Table 174. Asia Pertuzumab Sales Price by Country (2021-2026) & (US$/Ton) Table 175. Asia Pertuzumab Sales Price by Country (2027-2032) & (US$/Ton) Table 176. Japan Pertuzumab Revenue (2021-2032) & (US$ Million) Table 177. South Korea Pertuzumab Revenue (2021-2032) & (US$ Million) Table 178. India Pertuzumab Revenue (2021-2032) & (US$ Million) Table 179. Australia Pertuzumab Revenue (2021-2032) & (US$ Million) Table 180. Taiwan Pertuzumab Revenue (2021-2032) & (US$ Million) Table 181. Southeast Asia Pertuzumab Revenue (2021-2032) & (US$ Million) Table 182. SAMEA Pertuzumab Revenue by Type (2021-2026) & (US$ Million) Table 183. SAMEA Pertuzumab Revenue by Type (2027-2032) & (US$ Million) Table 184. SAMEA Pertuzumab Sales by Type (2021-2026) & (Tons) Table 185. SAMEA Pertuzumab Sales by Type (2027-2032) & (Tons) Table 186. SAMEA Pertuzumab Sales Price by Type (2021-2026) & (US$/Ton) Table 187. SAMEA Pertuzumab Sales Price by Type (2027-2032) & (US$/Ton) Table 188. SAMEA Pertuzumab Revenue by Application (2021-2026) & (US$ Million) Table 189. SAMEA Pertuzumab Revenue by Application (2027-2032) & (US$ Million) Table 190. SAMEA Pertuzumab Sales by Application (2021-2026) & (Tons) Table 191. SAMEA Pertuzumab Sales by Application (2027-2032) & (Tons) Table 192. SAMEA Pertuzumab Sales Price by Application (2021-2026) & (US$/Ton) Table 193. SAMEA Pertuzumab Sales Price by Application (2027-2032) & (US$/Ton) Table 194. SAMEA Pertuzumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 195. SAMEA Pertuzumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 196. SAMEA Pertuzumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 197. SAMEA Pertuzumab Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 198. SAMEA Pertuzumab Sales by Country (2021-2026) & (Tons) Table 199. SAMEA Pertuzumab Sales by Country (2027-2032) & (Tons) Table 200. SAMEA Pertuzumab Sales Price by Country (2021-2026) & (US$/Ton) Table 201. SAMEA Pertuzumab Sales Price by Country (2027-2032) & (US$/Ton) Table 202. Brazil Pertuzumab Revenue (2021-2032) & (US$ Million) Table 203. Argentina Pertuzumab Revenue (2021-2032) & (US$ Million) Table 204. Chile Pertuzumab Revenue (2021-2032) & (US$ Million) Table 205. Colombia Pertuzumab Revenue (2021-2032) & (US$ Million) Table 206. Peru Pertuzumab Revenue (2021-2032) & (US$ Million) Table 207. Saudi Arabia Pertuzumab Revenue (2021-2032) & (US$ Million) Table 208. Israel Pertuzumab Revenue (2021-2032) & (US$ Million) Table 209. UAE Pertuzumab Revenue (2021-2032) & (US$ Million) Table 210. Turkey Pertuzumab Revenue (2021-2032) & (US$ Million) Table 211. Iran Pertuzumab Revenue (2021-2032) & (US$ Million) Table 212. Egypt Pertuzumab Revenue (2021-2032) & (US$ Million) Table 213. Key Raw Materials Table 214. Raw Materials Key Suppliers Table 215. Pertuzumab Distributors List Table 216. Pertuzumab Customers List Table 217. Research Programs/Design for This Report Table 218. Authors List of This Report Table 219. Secondary Sources Table 220. Primary Sources List of Figures Figure 1. Pertuzumab Image Figure 2. Global Pertuzumab Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pertuzumab Market Size Share 2021 VS 2025 VS 2032 Figure 4. Human Source Image Figure 5. Animal Source Image Figure 6. Global Pertuzumab Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Pertuzumab Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Medical Center Image Figure 10. Global Pertuzumab Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Pertuzumab Revenue (2021-2032) & (US$ Million) Figure 12. Global Pertuzumab Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Pertuzumab Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Pertuzumab Revenue Market Share by Region (2021-2032) Figure 15. Global Pertuzumab Sales (2021-2032) & (Tons) Figure 16. Global Pertuzumab Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 17. Global Pertuzumab Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Pertuzumab Sales YoY (2021-2032) & (Tons) Figure 19. Europe Pertuzumab Sales YoY (2021-2032) & (Tons) Figure 20. China Pertuzumab Sales YoY (2021-2032) & (Tons) Figure 21. Asia (Excluding China) Pertuzumab Sales YoY (2021-2032) & (Tons) Figure 22. South America, Middle East and Africa Pertuzumab Sales YoY (2021-2032) & (Tons) Figure 23. Global Pertuzumab Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Pertuzumab Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Pertuzumab Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Pertuzumab Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Pertuzumab Revenue Market Share by Type (2021-2032) Figure 29. Global Pertuzumab Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 30. Global Pertuzumab Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Pertuzumab Sales Market Share by Type (2021-2032) Figure 32. Global Pertuzumab Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Pertuzumab Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Pertuzumab Revenue Market Share by Application (2021-2032) Figure 35. Global Pertuzumab Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 36. Global Pertuzumab Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Pertuzumab Sales Market Share by Application (2021-2032) Figure 38. North America Pertuzumab Revenue Share by Type (2021-2032) Figure 39. North America Pertuzumab Sales Share by Type (2021-2032) Figure 40. North America Pertuzumab Revenue Share by Application (2021-2032) Figure 41. North America Pertuzumab Sales Share by Application (2021-2032) Figure 42. North America Pertuzumab Revenue Share by Country (2021-2032) Figure 43. North America Pertuzumab Sales Share by Country (2021-2032) Figure 44. Europe Pertuzumab Revenue Share by Type (2021-2032) Figure 45. Europe Pertuzumab Sales Share by Type (2021-2032) Figure 46. Europe Pertuzumab Revenue Share by Application (2021-2032) Figure 47. Europe Pertuzumab Sales Share by Application (2021-2032) Figure 48. Europe Pertuzumab Revenue Share by Country (2021-2032) Figure 49. Europe Pertuzumab Sales Share by Country (2021-2032) Figure 50. China Pertuzumab Revenue Share by Type (2021-2032) Figure 51. China Pertuzumab Sales Share by Type (2021-2032) Figure 52. China Pertuzumab Revenue Share by Application (2021-2032) Figure 53. China Pertuzumab Sales Share by Application (2021-2032) Figure 54. Asia Pertuzumab Revenue Share by Type (2021-2032) Figure 55. Asia Pertuzumab Sales Share by Type (2021-2032) Figure 56. Asia Pertuzumab Revenue Share by Application (2021-2032) Figure 57. Asia Pertuzumab Sales Share by Application (2021-2032) Figure 58. Asia Pertuzumab Revenue Share by Country (2021-2032) Figure 59. Asia Pertuzumab Sales Share by Country (2021-2032) Figure 60. SAMEA Pertuzumab Revenue Share by Type (2021-2032) Figure 61. SAMEA Pertuzumab Sales Share by Type (2021-2032) Figure 62. SAMEA Pertuzumab Revenue Share by Application (2021-2032) Figure 63. SAMEA Pertuzumab Sales Share by Application (2021-2032) Figure 64. SAMEA Pertuzumab Revenue Share by Country (2021-2032) Figure 65. SAMEA Pertuzumab Sales Share by Country (2021-2032) Figure 66. Pertuzumab Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Pertuzumab Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Human Source
  • Animal Source
Applications
  • Hospital
  • Medical Center
Companies covered
  • Abnova Corporation
  • Biocon Limited
  • Bio-Techne
  • Celltrion
  • InvivoGen
  • Pfizer
  • Novartis AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pertuzumab Market by Type
  3. 1.2.1 Global Pertuzumab Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Human Source
  5. 1.2.3 Animal Source
  6. 1.3 Pertuzumab Market by Application
  7. 1.3.1 Global Pertuzumab Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Medical Center
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Pertuzumab Market Dynamics
  1. 2.1 Pertuzumab Industry Trends
  2. 2.2 Pertuzumab Industry Drivers
  3. 2.3 Pertuzumab Industry Opportunities and Challenges
  4. 2.4 Pertuzumab Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Pertuzumab Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Pertuzumab Revenue by Region
  3. 3.2.1 Global Pertuzumab Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pertuzumab Revenue by Region (2021-2026)
  5. 3.2.3 Global Pertuzumab Revenue by Region (2027-2032)
  6. 3.2.4 Global Pertuzumab Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Pertuzumab Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Pertuzumab Sales by Region
  9. 3.4.1 Global Pertuzumab Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Pertuzumab Sales by Region (2021-2026)
  11. 3.4.3 Global Pertuzumab Sales by Region (2027-2032)
  12. 3.4.4 Global Pertuzumab Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Pertuzumab Revenue by Manufacturers
  2. 4.1.1 Global Pertuzumab Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Pertuzumab Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Pertuzumab Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pertuzumab Sales by Manufacturers
  6. 4.2.1 Global Pertuzumab Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Pertuzumab Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Pertuzumab Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Pertuzumab Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Pertuzumab Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Pertuzumab Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Pertuzumab Manufacturers, Product Type & Application
  13. 4.7 Global Pertuzumab Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Pertuzumab Market CR5 and HHI
  16. 4.8.2 2025 Pertuzumab Tier 1, Tier 2, and Tier 3
5 Pertuzumab Market by Type
  1. 5.1 Global Pertuzumab Revenue by Type
  2. 5.1.1 Global Pertuzumab Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Pertuzumab Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Pertuzumab Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Pertuzumab Sales by Type
  6. 5.2.1 Global Pertuzumab Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pertuzumab Sales by Type (2021-2032) & (Tons)
  8. 5.2.3 Global Pertuzumab Sales Market Share by Type (2021-2032)
  9. 5.3 Global Pertuzumab Price by Type
6 Pertuzumab Market by Application
  1. 6.1 Global Pertuzumab Revenue by Application
  2. 6.1.1 Global Pertuzumab Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Pertuzumab Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Pertuzumab Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Pertuzumab Sales by Application
  6. 6.2.1 Global Pertuzumab Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Pertuzumab Sales by Application (2021-2032) & (Tons)
  8. 6.2.3 Global Pertuzumab Sales Market Share by Application (2021-2032)
  9. 6.3 Global Pertuzumab Price by Application
7 Company Profiles
  1. 7.1 Abnova Corporation
  2. 7.1.1 Abnova Corporation Company Information
  3. 7.1.2 Abnova Corporation Business Overview
  4. 7.1.3 Abnova Corporation Pertuzumab Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Abnova Corporation Pertuzumab Product Portfolio
  6. 7.1.5 Abnova Corporation Recent Developments
  7. 7.2 Biocon Limited
  8. 7.2.1 Biocon Limited Company Information
  9. 7.2.2 Biocon Limited Business Overview
  10. 7.2.3 Biocon Limited Pertuzumab Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Biocon Limited Pertuzumab Product Portfolio
  12. 7.2.5 Biocon Limited Recent Developments
  13. 7.3 Bio-Techne
  14. 7.3.1 Bio-Techne Company Information
  15. 7.3.2 Bio-Techne Business Overview
  16. 7.3.3 Bio-Techne Pertuzumab Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Bio-Techne Pertuzumab Product Portfolio
  18. 7.3.5 Bio-Techne Recent Developments
  19. 7.4 Celltrion
  20. 7.4.1 Celltrion Company Information
  21. 7.4.2 Celltrion Business Overview
  22. 7.4.3 Celltrion Pertuzumab Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Celltrion Pertuzumab Product Portfolio
  24. 7.4.5 Celltrion Recent Developments
  25. 7.5 InvivoGen
  26. 7.5.1 InvivoGen Company Information
  27. 7.5.2 InvivoGen Business Overview
  28. 7.5.3 InvivoGen Pertuzumab Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 InvivoGen Pertuzumab Product Portfolio
  30. 7.5.5 InvivoGen Recent Developments
  31. 7.6 Pfizer
  32. 7.6.1 Pfizer Company Information
  33. 7.6.2 Pfizer Business Overview
  34. 7.6.3 Pfizer Pertuzumab Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Pfizer Pertuzumab Product Portfolio
  36. 7.6.5 Pfizer Recent Developments
  37. 7.7 Novartis AG
  38. 7.7.1 Novartis AG Company Information
  39. 7.7.2 Novartis AG Business Overview
  40. 7.7.3 Novartis AG Pertuzumab Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Novartis AG Pertuzumab Product Portfolio
  42. 7.7.5 Novartis AG Recent Developments
8 North America
  1. 8.1 North America Pertuzumab Market Size by Type
  2. 8.1.1 North America Pertuzumab Revenue by Type (2021-2032)
  3. 8.1.2 North America Pertuzumab Sales by Type (2021-2032)
  4. 8.1.3 North America Pertuzumab Price by Type (2021-2032)
  5. 8.2 North America Pertuzumab Market Size by Application
  6. 8.2.1 North America Pertuzumab Revenue by Application (2021-2032)
  7. 8.2.2 North America Pertuzumab Sales by Application (2021-2032)
  8. 8.2.3 North America Pertuzumab Price by Application (2021-2032)
  9. 8.3 North America Pertuzumab Market Size by Country
  10. 8.3.1 North America Pertuzumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Pertuzumab Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Pertuzumab Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Pertuzumab Market Size by Type
  2. 9.1.1 Europe Pertuzumab Revenue by Type (2021-2032)
  3. 9.1.2 Europe Pertuzumab Sales by Type (2021-2032)
  4. 9.1.3 Europe Pertuzumab Price by Type (2021-2032)
  5. 9.2 Europe Pertuzumab Market Size by Application
  6. 9.2.1 Europe Pertuzumab Revenue by Application (2021-2032)
  7. 9.2.2 Europe Pertuzumab Sales by Application (2021-2032)
  8. 9.2.3 Europe Pertuzumab Price by Application (2021-2032)
  9. 9.3 Europe Pertuzumab Market Size by Country
  10. 9.3.1 Europe Pertuzumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Pertuzumab Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Pertuzumab Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Pertuzumab Market Size by Type
  2. 10.1.1 China Pertuzumab Revenue by Type (2021-2032)
  3. 10.1.2 China Pertuzumab Sales by Type (2021-2032)
  4. 10.1.3 China Pertuzumab Price by Type (2021-2032)
  5. 10.2 China Pertuzumab Market Size by Application
  6. 10.2.1 China Pertuzumab Revenue by Application (2021-2032)
  7. 10.2.2 China Pertuzumab Sales by Application (2021-2032)
  8. 10.2.3 China Pertuzumab Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pertuzumab Market Size by Type
  2. 11.1.1 Asia Pertuzumab Revenue by Type (2021-2032)
  3. 11.1.2 Asia Pertuzumab Sales by Type (2021-2032)
  4. 11.1.3 Asia Pertuzumab Price by Type (2021-2032)
  5. 11.2 Asia Pertuzumab Market Size by Application
  6. 11.2.1 Asia Pertuzumab Revenue by Application (2021-2032)
  7. 11.2.2 Asia Pertuzumab Sales by Application (2021-2032)
  8. 11.2.3 Asia Pertuzumab Price by Application (2021-2032)
  9. 11.3 Asia Pertuzumab Market Size by Country
  10. 11.3.1 Asia Pertuzumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Pertuzumab Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Pertuzumab Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pertuzumab Market Size by Type
  2. 12.1.1 SAMEA Pertuzumab Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Pertuzumab Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Pertuzumab Price by Type (2021-2032)
  5. 12.2 SAMEA Pertuzumab Market Size by Application
  6. 12.2.1 SAMEA Pertuzumab Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Pertuzumab Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Pertuzumab Price by Application (2021-2032)
  9. 12.3 SAMEA Pertuzumab Market Size by Country
  10. 12.3.1 SAMEA Pertuzumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Pertuzumab Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Pertuzumab Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Pertuzumab Value Chain Analysis
  2. 13.1.1 Pertuzumab Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Pertuzumab Production Mode & Process
  6. 13.2 Pertuzumab Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Pertuzumab Distributors
  9. 13.2.3 Pertuzumab Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst